November 20, 2018
Japan’s top three generic makers saw a 6.0% increase year on year in their combined sales in the first half of FY2018, with Nichi-Iko Pharmaceutical reporting a slight decline, and Sawai Pharmaceutical and Towa Pharmaceutical securing growth despite an NHI...read more